Antares Pharma

company

About

Antares Pharma is a specialty pharmaceutical company that focuses on commercializing therapeutic products.

  • 51 - 100

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$35M
Industries
Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 1979
Number Of Employee
51 - 100
Operating Status
Active

Antares Pharma is a revenue-generating product-focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA-approved products. Its products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. It focuses on self-injection pharmaceutical products and technologies and topical gel-based products. Its subcutaneous injection technology platforms include Vibex disposable pressure-assisted auto-injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$35M
Antares Pharma has raised a total of $35M in funding over 2 rounds. Their latest funding was raised on Jun 7, 2017 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 7, 2017 Post-IPO Debt $35M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Antares Pharma is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Post-IPO Debt